|09:15 - 09:30||Keynote Address||Henru Krüger - ASAIPA|
|09:30 - 10:00||Patient Blood Management (PBM)||Dr Petro-Lize Wessels - South African
National Blood Service
|10:00 - 10:30||Digital Transformation in Healthcare||Bryan Sidders - Prior Ditema (Pty) Ltd|
|10:30 - 11:00||The Digitised Practice of the future||Luis da Silva, Managing Director - Healthbridge|
|11:00 - 11:30||Break|
|11:30 - 12:00||Breaking bad news||Julia Ambler - The Medical Protection
|12:00 - 12:30||The Biggest Current Epidemic in the World||Dr Raath - Raath Wellness Innovation Ltd|
|12:30 - 13:30||Lunch|
|13:30 - 14:00||The Changing Shape of HealthCare- Incorporating Technology and Telehealth Into Your Practice for Enhanced Efficiencies.||Neil Kinsley, CEO - Medici|
|14:00 - 14:30||An update on proctology and role of colonoscopy||Dr. Amisha Maraj|
|14:30 - 15:00||Future Health & Smart Health Communities (SHC)||Henru Krüger - ASAIPA|
|15:00 - 15:30||Break|
|15:30 - 16:00||Applying pharmacogenomics to clinical practice||Debra Langley, BPharm NHN NHC, Pharmacist at Geneway|
|16:00 - 16:30||Cellular therapies and Novel Products||Dr Colwyn Poole - South African National Blood Service|
|16:30 - 16:45||A gap in the communites that must be filled!||Percy Williamson - CEO of Melela 4 Children|
Henru Krüger, Chief Operating Officer, The Alliance of South African Independent Practitioners Associations (ASAIPA), Pretoria, South Africa.
Henru holds a degree in law from the University of Pretoria and is an admitted attorney to the High Court of South Africa. He also completed a financial degree at the University of South Africa, has served articles in Audit Specialism, and is a Certified Internal Auditor and Compliance Professional. He has previously worked in legal practice, external audit practice and the medical schemes’ industry, and is the current Chief Operational Officer (COO) of the Alliance of South African Independent Practitioners Associations (ASAIPA) that represents a membership of more than a thousand family practitioners in private practice in South Africa.
Talk will be on Smart Health Communities (SHC)
Health care starts in the community— the move should be away from traditional health care players, with non-traditional market entrants, and government agencies establishing smart health communities to empower individuals in the community to take charge of their health.
Bryan Sidders successfully conducted 6 Start-up Companies - 4 small, 2 large which is still successful today. Bryan has 45 years’ experience in the RSA Health Care Industry. He has extensive Management, Executive and Leadership experience. Through many years of Consulting he often acted as Business Analyst to identify & Conceptualise Computer Systems to automate Processes in Administration and Information Systems amongst others at Alexander Forbes Healthcare in setting up and running the Healthcare Division.
In 1990, Luis da Silva obtained a BSc (Electrical Engineering) with distinction from Wits. His major interest was in control theory. During his four years of study he was the recipient of many awards, most notable was the “Bernard Price Award for Most Distinguished Final Year Student” in 1990.
After having been granted a bursary, Luis worked at Siemens for four years as a systems engineer in the process automation division. He was involved in the design and implementation of sophisticated automation projects in the steel, breweries, automobile and power industries. One of his highlights was the ALUSAF Hillside Smelter project where he was a key member of the German-based design team.
Having proved himself as an engineer, Luis decided it was time to be exposed to sales. In 1996 he joined Adroit Technologies, a South African-based company that developed software for the process automation industry. He soon rose from sales engineer, to international business development manager, and ultimately commercial divisional manager responsible for sales, marketing, support, training and international business development. His key achievements were in increasing sales by 57% in his first year, creating a network of over 40 value-added resellers and securing international distributorship agreements for the Adroit software product in Europe and Australia.
Dr Russell Raathis a specialist anaesthesiologist who now treats chronic pain only, at the Chronic Pain Centre. About 15% of the world population is battling chronic pain and medicine has failed them by ignoring them or pretending they do not exist and by not doing much to study it, understand it and treat it properly. Dr Raath acknowledges their pain and has developed treatment protocols to help people with ALL types of chronic pain. As fear of a global opiate crisis grows daily, the alternative to manage pain without opiates lies in interventions for chronic pain. The cause of the pain can usually be identified and treated with a wide range of interventions without using opiates.
Neil Kinsley is the CEO of Medici, a company focused on developing new an innovative Telehealth strategies, based in Austin, Texas.?
Neil’s background stems from healthcare financing and insurance having spent 24 years, in various roles, with Discovery.
Having been exposed to telehealth both in the U.S and South Africa, he has valuable experience in every realm of Telehealth, including implementation, strategies and legalities.
He is a founder member of the Digital Healthcare Association, which was formed to create practice guidelines for South African Telemedicine.
What if there was a way to know how a depressed patient would respond to an antidepressant – before it was prescribed? Or to predict the success rate of a breast cancer fighter on drug therapy?
In recent years, advances in the field of DNA testing has made such drug-response predictions possible for patients with certain gene variants. Pharmacogenomics provides us with extraordinarily useful information for drug safety, in that it can anticipate possible side effects occurrence associated with certain genetic make-up. It increases treatment efficacy as effective drugs are prescribed in the correct dosages matching a patient's genetic characteristics. This ensures that prescriptions are no longer a “one pill for all” approach but carefully thought out protocols providing the right drug to the right patient at the right dose.